Summit Therapeutics Inc. (SMMT)
NASDAQ · Healthcare
Summit Therapeutics Inc. annual/quarterly total liabilities history from 2019 to 2024. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Summit Therapeutics Inc. total liabilities for the quarter ending December 31, 2024 were 46.8M, a 62.63% decrease year-over-year.
- Summit Therapeutics Inc. total liabilities for 2024 were 46.8M, a 62.63% decrease from 2023.
- Summit Therapeutics Inc. total liabilities for 2023 were 125.3M, a 76.70% decrease from 2022.
- Summit Therapeutics Inc. total liabilities for 2022 were 537.5M, a 1686.35% increase from 2021.
- Summit Therapeutics Inc. total liabilities for 2021 were 30.1M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Summit Therapeutics Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2024 | $47 |
| 2023 | $125 |
| 2022 | $538 |
| 2021 | $30 |
| 2020 | $23 |
| 2019 | $17 |
| Summit Therapeutics Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2024-12-31 | $47 |
| 2023-12-31 | $125 |
| 2022-12-31 | $538 |
| 2021-12-31 | $30 |
| 2020-12-31 | $23 |
| 2019-12-31 | $17 |
Summit Therapeutics Inc. Total Liabilities — FAQ
Summit Therapeutics Inc. (SMMT) total liabilities over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see SMMT's total liabilities history?
The chart and table above show Summit Therapeutics Inc.'s total liabilities by year and by quarter, including the growth rate.